@azza64
#ESMO25
Thank you to the scientific committee for selecting our work for oral presentation:
Patient-level analysis of Pneumonitis in Nivo-based regimens for solid tumors:
- 11,777pts, 716 with pneumonitis (6.1%)
- risk factors: age >65; NSCLC, smoking+, Ipi/nivo (p<0.005)
1/3View quoted post on X
Circulating Tumor DNA-Guided De-Escalation Targeted Therapy for Advanced Lung CancerView quoted post on X
👉 super interesting for oligometastatic patients and guiding us about maintenance therapy after completion of definitive local therapy
jamanetwork.com/journals/jamao…
• The two figures that I liked the most from ASCO. The LAURA and ADRIATIC trials demonstrate that the combination of radiotherapy with systemic treatments can cure our patients with lung cancer 🙏🏻🎯View quoted post on X
Here are the updated OS curves of patients with clinical stage IIIA-B NSCLC treated with dual immunotherapy in the randomized phase II COAST trial. #ASCO24 #radonc
FUN FACT: the local treatment was radiotherapy, not surgery.View quoted post on X
